[Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium]

Rev Argent Microbiol. 2009 Jan-Mar;41(1):34-8.
[Article in Spanish]

Abstract

Five patients hospitalized in the neonatal unit between 2002 and 2007, infected with vancomycin-resistant Enterococcus faecium treated with linezolid are presented in this study. This antibiotic showed good clinical efficacy and safety, since no adverse events occured in this group of patients.

Publication types

  • English Abstract

MeSH terms

  • Acetamides / therapeutic use*
  • Argentina / epidemiology
  • Comorbidity
  • Cross Infection / drug therapy*
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Endocarditis, Bacterial / drug therapy
  • Endocarditis, Bacterial / microbiology
  • Enterococcus faecium / drug effects*
  • Enterococcus faecium / isolation & purification
  • Enterocolitis, Necrotizing / epidemiology
  • Gram-Positive Bacterial Infections / drug therapy*
  • Gram-Positive Bacterial Infections / epidemiology
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases / drug therapy
  • Infant, Premature, Diseases / microbiology
  • Intensive Care Units, Neonatal
  • Linezolid
  • Male
  • Opportunistic Infections / drug therapy
  • Opportunistic Infections / epidemiology
  • Opportunistic Infections / microbiology
  • Oxazolidinones / therapeutic use*
  • Peritonitis / drug therapy
  • Peritonitis / epidemiology
  • Risk Factors
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / microbiology
  • Vancomycin Resistance*

Substances

  • Acetamides
  • Oxazolidinones
  • Linezolid